Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
F
Fandy, Tamer
Univ of Charleston
151
:
Genome-Wide CpG Methylation Profiling of Leukemia Cells Treated With Curcuminoids
Tamer Fandy
Favorite
Fang, Yunlan
Incyte Corporation
153
:
Population Pharmacokinetics/Pharmacodynamics Modeling of INCAGN02385 in Patients With Select Advanced Malignancies
Yunlan Fang
Favorite
Ford, Jennifer
Janssen Research & Development, LLC, a Johnson & Johnson Company
047
:
How Much PK Data Do We Really Need in Phase 3? A Milvexian Case Study
Jennifer Ford
Favorite
Franke, Ryan
Pfizer Inc
102
:
Sisunatovir Inhibition of Multiple Ion Channel Subtypes Prevents the Risk for QT Prolongation Due to hERG Channel Inhibition
Ryan Franke
Favorite
Frazier, Noah
Boehringer Ingelheim Intl GmbH
080
:
Is it Time to Retire Cockcroft-Gault & “Original” Schwarz Formulas in Drug Development?
Noah Frazier
Favorite
